Chinese pharmaceutical company (600056.SH) subsidiary, Sodium Diclofenac Enteric-coated Tablets, passed the consistency evaluation of generic drugs.

Wisdom Financial APP news, China Pharmaceutical (600056.SH) announced that recently, its wholly-owned subsidiary Tianfang Pharmaceutical Co., Ltd. ("Tianfang Pharmaceutical") received the approval notice for the supplementary application of sodium diclofenac enteric-coated tablets issued by the National Medical Products Administration. This drug has passed the evaluation of generic drug quality and efficacy consistency. Sodium diclofenac enteric-coated tablets are mainly used for inflammatory and degenerative rheumatic diseases, various non-articular soft tissue rheumatic pain, acute attacks of gout, acute mild to moderate pain, and can be used as adjuvant therapy for severe painful infections of the ear, nose, and throat.